查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1464979

Biperiden市場：按劑量、按應用 - 全球預測 2024-2030

Biperiden Market by Administration (Injection, Oral), Application (Drug-induced Movement Disorders, Parkinson Disease, Touret Syndrome) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年比Biperiden市場規模為3.6427億美元，2024年將達3.847億美元，2030年將達5.3676億美元，複合年成長率為5.69%。

Biperiden是一種藥物化合物，被歸類為抗膽鹼能藥物，主要用於其抗痙攣和抗帕金森氏症作用。它透過阻斷中樞和周圍神經系統中的乙醯膽鹼受體來發揮作用。這一動作有助於減輕與帕金森氏症相關的症狀，例如僵硬、顫抖和唾液分泌過多。此外，Biperiden也用於抵消抗精神病藥物的副作用，例如不自主的肌肉運動。多種劑型，包括口服和注射製劑，可靈活給藥以滿足患者需求。與所有藥物一樣，Biperiden的使用必須在醫療專業人員的指導下嚴格控制，以平衡治療效果和潛在副作用。全球帕金森氏症患者數量的不斷增加正在推動Biperiden的需求。老年人口的成長推動了Biperiden的需求增加，因為老年人更容易罹患帕金森氏症。此外，提高Biperiden療效並減少副作用的持續研究也促進了市場的成長。然而，Biperiden具有抗膽鹼能副作用，例如口乾、視力模糊和便秘，這可能限制其在某些患者中的使用。然而，開發具有改進的遞送機制、減少的副作用和提高的患者依從性的比Biperiden製劑提供了巨大的機會。隨著醫療保健支出不斷增加和患者群體開拓，向新興市場擴張具有巨大的成長潛力。

主要市場統計
基準年[2023] 3.6427 億美元
預測年份 [2024] 3.847 億美元
預測年份 [2030] 53676萬美元
複合年成長率（%） 5.69%

易於給藥和患者依從性增加了對口服給藥的偏好

Biperiden登注射液主要用於無法口服給藥的急性病症的快速症狀控制。注射劑是治療急性肌張力失調反應的有效方法，因為它們的血漿濃度很快就達到高峰。這種給藥途徑需要醫療保健專業人員的密切給藥和監測，以減少抗膽鹼能副作用等潛在風險。Biperiden因其易於使用和患者依從性而被廣泛用於長期管理。它以錠劑形式提供，可緩釋藥物並全天保持穩定的血漿濃度。這種方法適用於治療慢性病，並允許患者以最少的干擾維持規律的日常生活。

應用實例 比Biperiden作為有效抗膽鹼能藥物在藥物引起的運動障礙中的增殖

Biperiden是一種強效抗膽鹼能藥物，常用於治療藥物引起的運動障礙 (DIMD)。 DIMD 通常是抗精神病藥物的副作用，抗精神病藥物主要用於治療各種精神疾病。這些運動障礙表現為肌張力不全症、靜坐不能、帕金森氏症和遲發性。Biperiden透過阻斷乙醯膽鹼受體來矯正抗精神病藥物引起的大腦神經傳導物質失衡。它可以緩解肌肉僵硬、震顫和不自主肌肉運動等症狀，顯著改善 DIMD 患者的生活品質。帕金森氏症是退化性疾病。透過拮抗乙醯膽鹼的作用，Biperiden登恢復大腦中多巴胺和乙醯膽鹼之間的平衡。這種調整有助於緩解與帕金森氏症相關的運動症狀，但它不會逆轉疾病的進展或影響非運動症狀。妥瑞症是一種神經系統疾病，會導致重複性、常規性不自主運動和發聲，稱為抽動。妥瑞症的療效很大程度上取決於患者個體對藥物的反應和症狀的性質。Biperiden的抗膽鹼能作用可能有助於緩解某些運動抽搐，但臨床醫生必須仔細權衡其益處和潛在副作用。

區域洞察

美洲Biperiden市場的特點是醫療基礎設施強大、對神經系統疾病的認知度高以及監管支持有力。美國是該地區最大的市場，由於人口老化以及帕金森氏症和錐體外系症狀的流行，需求量很大。監管核准和保險覆蓋政策對該地區的市場動態產生重大影響。此外，由於醫療設施的改善、醫療成本的上升以及對神經系統疾病的認知的提高，拉丁美洲顯示出廣泛的成長潛力。在歐洲、中東和非洲地區，歐洲因其先進的醫療體系、高昂的醫療費用以及帕金森氏症患者病率的上升而成為Biperiden登的核心市場。老牌製藥公司的存在和有利的法規環境進一步推動了市場的發展。由於人口快速成長、醫療保健需求增加以及帕金森氏症和其他相關疾病盛行率的增加，亞太地區正在經歷有利的市場條件。中國、印度等國家因其龐大的人口基數和快速發展的醫療保健產業而佔據著舉足輕重的地位。醫療基礎設施投資的增加、中階人口的成長以及對神經系統疾病的認知不斷提高是推動該地區市場的關鍵因素。

FPNV定位矩陣

FPNV定位矩陣對於評估比Biperiden市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限。最前線 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對Biperiden市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析也為此細分市場的競爭特徵提供了寶貴的見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：包括新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：包括對未來技術、研發活動和突破性產品開發的智力見解。

本報告解決了以下關鍵問題：

1.Biperiden市場的市場規模和預測是多少？

2.在Biperiden市場預測期內需要考慮投資的產品、細分市場、應用和細分市場有哪些？

3. Biperiden市場的技術趨勢和法規結構是什麼？

4.Biperiden市場主要供應商的市場佔有率是多少？

5. 進入Biperiden市場的適當型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球Biperiden登治療巴金森氏症的使用量增加
      • 在治療藥物引起的運動障礙的藥物開發中增加使用Biperiden
    • 抑制因素
      • Biperiden生產認知度低、成本高
    • 機會
      • 持續研發，增強Biperiden藥物的適用性
      • 製藥公司對比Biperiden生產的新投資
    • 任務
      • 比Biperiden登相關的潛在健康影響
  • 市場區隔分析
    • 劑量：由於易於使用和患者依從性，口服給藥越來越受歡迎
    • 用途：Biperiden作為有效抗膽鹼能藥物在藥物引起的運動障礙的推廣
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章Biperiden市場管理

  • 介紹
  • 注射
  • 口服

第7章Biperiden市場：依應用

  • 介紹
  • 藥物引起的運動障礙
  • 帕金森氏症
  • 妥瑞症

第8章 美洲Biperiden市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太比Biperiden市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲Biperiden市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

第12章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-351BAD503D4E

[197 Pages Report] The Biperiden Market size was estimated at USD 364.27 million in 2023 and expected to reach USD 384.70 million in 2024, at a CAGR 5.69% to reach USD 536.76 million by 2030.

Biperiden is a pharmaceutical compound classified as an anticholinergic agent, primarily utilized for its antispasmodic and antiparkinsonian properties. It operates by blocking acetylcholine receptors in the central and peripheral nervous system. This action helps in reducing the symptoms associated with Parkinson's disease, such as rigidity, tremors, and excessive salivation. Additionally, biperiden is employed to counteract the side effects of antipsychotic medications, including involuntary muscle movements. Its availability in various forms, including oral and injectable, allows for flexibility in administration based on patient needs. As with all medications, the use of biperiden must be closely managed under the guidance of a healthcare professional to balance therapeutic benefits against potential side effects. The increasing number of Parkinson's disease cases globally drives the demand for Biperiden. As older age groups are more prone to Parkinson's, the expanding elderly demographic fosters an Increasing need for biperiden. Moreover, Continuous research on improving Biperiden's efficacy and reducing side effects contributes to market growth. However, biperiden's anticholinergic side effects, such as dry mouth, blurred vision, and constipation, may limit its usability for some patients. Nevertheless, the development of biperiden formulations with improved delivery mechanisms, reduced side effects, and enhanced patient compliance presents significant opportunities. Expanding into emerging markets with increasing healthcare expenditure and untapped patient demographics offers considerable growth potential.

KEY MARKET STATISTICS
Base Year [2023] USD 364.27 million
Estimated Year [2024] USD 384.70 million
Forecast Year [2030] USD 536.76 million
CAGR (%) 5.69%

Administration: Increasing preferences for Oral administration owing to their ease of use and patient compliance

The injectable form of Biperiden is primarily used for rapid symptom control in acute episodes where oral administration is not feasible. The injectable route provides quick plasma concentration peaks, making it an efficient method for managing acute dystonic reactions. This administration route demands meticulous dosing and monitoring by healthcare professionals to mitigate potential risks such as anticholinergic side effects. Oral administration of Biperiden is widely utilized for long-term management due to its ease of use and patient compliance. Available in tablet form, it allows for a sustained release of the medication, facilitating stable plasma concentrations throughout the day. This method is preferable for managing chronic symptoms, allowing patients to maintain regular daily activities with minimal disruption.

Application: Proliferation of biperiden in drug-induced movement disorders as potent anticholinergic agent

Biperiden is a potent anticholinergic agent that is frequently used in the management of drug-induced movement disorders (DIMDs). DIMDs are often a side effect of antipsychotic medications, which are primarily used to treat various psychiatric disorders. These movement disorders can manifest as dystonia, akathisia, parkinsonism, and tardive dyskinesia. Biperiden works by blocking acetylcholine receptors, thereby correcting the imbalance of neurotransmitters in the brain caused by antipsychotic medications. It serves to alleviate symptoms such as muscle stiffness, tremors, and involuntary muscle movements, significantly improves the patients quality of life suffering from DIMDs. Parkinson's Disease depicts degenerative disorder of the central nervous system, affecting the motor system. By antagonizing the action of acetylcholine, biperiden helps restore the balance between dopamine and acetylcholine in the brain. This adjustment aids in alleviating the motor symptoms associated with Parkinson's Disease, although it does not reverse the disease progression or affect the non-motor symptoms. Tourette Syndrome is a type of neurological disorder that depicts repetitive, stereotyped, involuntary movements and vocalizations called tics. Its efficacy in Tourette Syndrome largely depends on the individual patient's response to the medication and the nature of their symptoms. The anticholinergic action of biperiden can help mitigate certain motor tics, but clinicians should carefully weigh its benefits against potential side effects.

Regional Insights

The Biperiden market in the Americas is characterized by a robust healthcare infrastructure, high awareness of neurological disorders, and strong regulatory support. The United States, being the largest market in the region, demonstrates significant demand due to an aging population and the prevalence of Parkinson's disease and extrapyramidal symptoms. Regulatory approvals and insurance coverage policies significantly influence the market dynamics in this region. Furthermore, Latin America shows promising growth potential, attributed to improving healthcare facilities, rising healthcare expenditures, and increasing awareness of neurological disorders. In the EMEA region, Europe stands out as a central market for biperiden, supported by its advanced healthcare systems, high spending on healthcare, and an increasing incidence of Parkinson's disease. The presence of well-established pharmaceutical companies, coupled with favorable regulatory environments, further drives the market. The Asia Pacific region shows an opportunistic landscape for the growth of the biperiden market, driven by burgeoning populations, escalating healthcare needs, and increasing prevalence of Parkinson's disease and other related disorders. Countries including China and India are pivotal due to their immense population base and rapidly evolving healthcare sectors. Increased investments in healthcare infrastructure, growing middle-class populations, and rising awareness about neurological disorders are key factors propelling the market in this region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biperiden Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biperiden Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biperiden Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., ACTYLIS, Adooq Bioscience LLC, BioCrick BioTech, Biotechne Corporation, Clearsynth, Enomark, MANUS AKTTEVA BIOPHARMA LLP, Merck KGaA, NIKSAN PHARMACEUTICAL, Rafa Laboratories Ltd., SAKHIYA PHARMA CHEM, Salvavidas Pharmaceutical Pvt. Ltd., Shreeji Pharma International, Simson Pharma, and Synnat Pharma.

Market Segmentation & Coverage

This research report categorizes the Biperiden Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Administration
    • Injection
    • Oral
  • Application
    • Drug-induced Movement Disorders
    • Parkinson Disease
    • Touret Syndrome
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Biperiden Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biperiden Market?

3. What are the technology trends and regulatory frameworks in the Biperiden Market?

4. What is the market share of the leading vendors in the Biperiden Market?

5. Which modes and strategic moves are suitable for entering the Biperiden Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing use of biperiden to treat parkinson's disease globally
      • 5.1.1.2. Rising usage of biperiden in drug developement of drug-induced movement disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness and high cost of biperiden manufacturing
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development to enhance the applicability of biperiden-based drugs
      • 5.1.3.2. Emerging investments by pharmaceutical companies in biperiden production
    • 5.1.4. Challenges
      • 5.1.4.1. Potential health affects associated with biperiden
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Administration: Increasing preferences for Oral administration owing to their ease of use and patient compliance
    • 5.2.2. Application: Proliferation of biperiden in drug-induced movement disorders as potent anticholinergic agent
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Biperiden Market, by Administration

  • 6.1. Introduction
  • 6.2. Injection
  • 6.3. Oral

7. Biperiden Market, by Application

  • 7.1. Introduction
  • 7.2. Drug-induced Movement Disorders
  • 7.3. Parkinson Disease
  • 7.4. Touret Syndrome

8. Americas Biperiden Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biperiden Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biperiden Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Merck Seals USD 610 Million Biobucks Deal to Acquire Preclinical Neurodegenerative Biotech Caraway
    • 11.3.2. AbbVie Acquires Parkinson's Drug in Latest Biotech Buyout
    • 11.3.3. Serina-AgeX Merger to Develop Treatment for Advanced Parkinson's
  • 11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

  • 12.1. Key Company Profiles
  • 12.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. BIPERIDEN MARKET RESEARCH PROCESS
  • FIGURE 2. BIPERIDEN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIPERIDEN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIPERIDEN MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BIPERIDEN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BIPERIDEN MARKET DYNAMICS
  • FIGURE 7. GLOBAL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BIPERIDEN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BIPERIDEN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES BIPERIDEN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES BIPERIDEN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. BIPERIDEN MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 20. BIPERIDEN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIPERIDEN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIPERIDEN MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BIPERIDEN MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIPERIDEN MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BIPERIDEN MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIPERIDEN MARKET SIZE, BY INJECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BIPERIDEN MARKET SIZE, BY INJECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIPERIDEN MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BIPERIDEN MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIPERIDEN MARKET SIZE, BY DRUG-INDUCED MOVEMENT DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BIPERIDEN MARKET SIZE, BY DRUG-INDUCED MOVEMENT DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIPERIDEN MARKET SIZE, BY PARKINSON DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BIPERIDEN MARKET SIZE, BY PARKINSON DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIPERIDEN MARKET SIZE, BY TOURET SYNDROME, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BIPERIDEN MARKET SIZE, BY TOURET SYNDROME, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. AMERICAS BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 22. AMERICAS BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 23. AMERICAS BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 24. AMERICAS BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 25. AMERICAS BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 26. AMERICAS BIPERIDEN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 27. ARGENTINA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 28. ARGENTINA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 29. ARGENTINA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 30. ARGENTINA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 31. BRAZIL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 32. BRAZIL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 33. BRAZIL BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 34. BRAZIL BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 35. CANADA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 36. CANADA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 37. CANADA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 38. CANADA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 39. MEXICO BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 40. MEXICO BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 41. MEXICO BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 42. MEXICO BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 43. UNITED STATES BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 44. UNITED STATES BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 45. UNITED STATES BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 46. UNITED STATES BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 47. UNITED STATES BIPERIDEN MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 48. UNITED STATES BIPERIDEN MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 56. AUSTRALIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 58. AUSTRALIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 59. CHINA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 60. CHINA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 61. CHINA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. CHINA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. INDIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 64. INDIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 65. INDIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 66. INDIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 67. INDONESIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 68. INDONESIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 69. INDONESIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. INDONESIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. JAPAN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 72. JAPAN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 73. JAPAN BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 74. JAPAN BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 75. MALAYSIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 76. MALAYSIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 77. MALAYSIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 78. MALAYSIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 80. PHILIPPINES BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. PHILIPPINES BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. SINGAPORE BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 84. SINGAPORE BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 85. SINGAPORE BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 86. SINGAPORE BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 88. SOUTH KOREA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 90. SOUTH KOREA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 91. TAIWAN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 92. TAIWAN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 93. TAIWAN BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. TAIWAN BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. THAILAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 96. THAILAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 97. THAILAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 98. THAILAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 99. VIETNAM BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 100. VIETNAM BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 101. VIETNAM BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. VIETNAM BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 109. DENMARK BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 110. DENMARK BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 111. DENMARK BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. DENMARK BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. EGYPT BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 114. EGYPT BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 115. EGYPT BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 116. EGYPT BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 117. FINLAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 118. FINLAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 119. FINLAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. FINLAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. FRANCE BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 122. FRANCE BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 123. FRANCE BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. FRANCE BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. GERMANY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 126. GERMANY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 127. GERMANY BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. GERMANY BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. ISRAEL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 130. ISRAEL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 131. ISRAEL BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. ISRAEL BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. ITALY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 134. ITALY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 135. ITALY BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. ITALY BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 138. NETHERLANDS BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 140. NETHERLANDS BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 141. NIGERIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 142. NIGERIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 143. NIGERIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. NIGERIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. NORWAY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 146. NORWAY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 147. NORWAY BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. NORWAY BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. POLAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 150. POLAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 151. POLAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. POLAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. QATAR BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 154. QATAR BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 155. QATAR BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. QATAR BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. RUSSIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 158. RUSSIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 159. RUSSIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 160. RUSSIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 162. SAUDI ARABIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. SAUDI ARABIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 166. SOUTH AFRICA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. SOUTH AFRICA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. SPAIN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 170. SPAIN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 171. SPAIN BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 172. SPAIN BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 173. SWEDEN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 174. SWEDEN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 175. SWEDEN BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. SWEDEN BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 178. SWITZERLAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. SWITZERLAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. TURKEY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 182. TURKEY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 183. TURKEY BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. TURKEY BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 190. UNITED KINGDOM BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. UNITED KINGDOM BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. BIPERIDEN MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. BIPERIDEN MARKET, FPNV POSITIONING MATRIX, 2023